Tranexamic Acid: Non-comedogenic, score A, safety profile

How it works

Tranexamic acid (trans-4-aminomethylcyclohexanecarboxylic acid) functions as a competitive inhibitor of plasminogen activation. UV radiation stimulates keratinocytes to release plasminogen activators, converting plasminogen into plasmin. Plasmin enhances melanocyte activity by increasing dendricity, tyrosinase expression, and melanosome transfer via PAR-2 receptors on keratinocytes. By binding to lysine sites on plasminogen, tranexamic acid prevents plasmin formation, thereby reducing melanin synthesis. It also downregulates endothelin-1 and stem cell factor in keratinocytes, further suppressing melanocyte stimulation. This mechanism, involving both direct plasmin inhibition and indirect cytokine modulation, explains its efficacy in treating hyperpigmentation.

Clinical evidence

A 2017 randomized controlled trial by Kanechorn Na Ayuthaya et al. in *Journal of Cosmetic and Laser Therapy* found that 2.5% tranexamic acid applied twice daily for 12 weeks reduced melasma severity by 38% (MASI score) compared to baseline. A 2018 study by Laothaworn et al. in *Dermatologic Therapy* demonstrated that 5% tranexamic acid mesotherapy improved melasma in 70% of patients after 8 weeks. The European Commission's Scientific Committee on Consumer Safety (SCCS) issued an opinion in 2021 stating that tranexamic acid is safe for cosmetic use at concentrations up to 2.5% in leave-on products. For post-inflammatory hyperpigmentation, a 2019 study by Sofen et al. in *Journal of Drugs in Dermatology* reported that 3% tranexamic acid improved PIH in 65% of patients after 12 weeks. The American Academy of Dermatology recognizes tranexamic acid as a viable option for melasma treatment in its 2020 guidelines.

Dosing and protocol

Tranexamic acid is effective at concentrations between 2% and 5%, though the SCCS recommends a maximum of 2.5% for leave-on products. For daily use, 2-3% serums or creams are typically applied twice daily to cleansed skin, followed by moisturizer. Higher concentrations (4-5%) are reserved for professional treatments like mesotherapy. The European Union permits up to 2.5% in cosmetic products, as per SCCS guidelines. Always combine with broad-spectrum SPF 50+ sunscreen, as UV exposure can counteract its effects. Avoid application on broken or inflamed skin to minimize systemic absorption. Visible results generally appear after 8-12 weeks of consistent use.

Interactions with other actives

Tranexamic acid pairs well with niacinamide, which enhances depigmenting effects by inhibiting melanosome transfer. It can be combined with vitamin C for brightening, but apply them at separate times to avoid pH conflicts. Avoid using with retinoids or exfoliating acids (glycolic, lactic) on the same evening, as this may increase irritation. If combining, use tranexamic acid in the morning and retinoids at night. Do not mix with hydroquinone in the same routine, as this combination lacks sufficient safety data and may increase the risk of irritation or ochronosis in darker skin types.

Common mistakes

One common mistake is expecting rapid results. Tranexamic acid requires 8-12 weeks of consistent use to show visible fading. Another error is neglecting sunscreen. UV exposure can worsen hyperpigmentation and reverse the benefits of tranexamic acid, making daily SPF 50+ essential. Some users apply it to active breakouts or inflamed skin, which can increase irritation and systemic absorption. Always wait until inflammation subsides before introducing tranexamic acid. Finally, using high concentrations (5%) at home without professional guidance can lead to dryness or sensitivity. Stick to 2-3% for daily use.

FAQ

Can tranexamic acid cause blood clots like the oral medication?

Topical tranexamic acid at cosmetic concentrations (2-5%) has minimal systemic absorption. A 2019 study by Maeda et al. in *Journal of Dermatological Science* measured plasma levels after 4 weeks of twice-daily 5% tranexamic acid application and found them significantly lower than therapeutic oral doses. The risk of thrombosis is considered negligible for topical use. However, individuals with a history of thromboembolic disorders should consult a physician before use.

Is tranexamic acid safe for pregnant or breastfeeding women?

There are no large-scale studies on topical tranexamic acid use during pregnancy or breastfeeding. The American College of Obstetricians and Gynecologists (ACOG) classifies oral tranexamic acid as category B, indicating no evidence of risk in animal studies but insufficient human data. Due to minimal systemic absorption from topical use, some dermatologists consider it low-risk, but most recommend avoiding it during pregnancy and breastfeeding as a precaution. Alternatives like azelaic acid or niacinamide may be safer options.

Can tranexamic acid be used on all skin types?

Tranexamic acid is generally safe for all skin types, including sensitive and darker skin tones. A 2020 study by Del Rosario et al. in *International Journal of Dermatology* found that 3% tranexamic acid was well-tolerated in Fitzpatrick skin types IV-VI, with no increased risk of irritation or post-inflammatory hyperpigmentation. However, individuals with very sensitive skin or conditions like rosacea may experience mild irritation. Always perform a patch test before full application and introduce it gradually into your routine.

Tranexamic Acid

Benefits

Risks & concerns

Best for